1-4 of 4
Frank Neumann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11

Michael D. Jain, David B. Miklos, Caron A. Jacobson, John M. Timmerman, Jennifer Sun, Jenny Nater, Xiang Fang, Ankit Patel, Madison Davis, Darren Heeke, Tan Trinh, Mike Mattie, Frank Neumann, Jenny J. Kim, Christina To, Simone Filosto, Ran Reshef
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF10.
https://doi.org/10.1158/1078-0432.CCR-23-0916
Published: 30 August 2023
View article titled, Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Open the PDF for Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11 in another window
Includes: Supplementary data
Journal Articles

Abstract B22: Genome-wide methylation analysis reveals an independently validated CpG island methylator phenotype associated with favorable prognosis in acute myeloid leukemia.

Andrew D. Kelly, Heike Kroeger, Jumpei Yamazaki, Rodolphe Taby, Frank Neumann, Justin T. Lee, Rong He, Shoudan Liang, Yue Lu, Matteo Cesaroni, Sherry A. Pierce, Steven M. Kornblau, Carlos E. Bueso-Ramos, Farhad Ravandi, Hagop M. Kantarjian, Jean-Pierre J. Issa, Jaroslav Jelinek
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17_Supplement): B22.
https://doi.org/10.1158/1557-3265.HEMMAL14-B22
Published: 19 August 2015
View article titled, Abstract B22: Genome-wide methylation analysis reveals an independently validated CpG island methylator phenotype associated with favorable prognosis in acute myeloid leukemia.
Journal Articles

Measuring tumor cell apoptosis and necrosis in blood samples of cancer patients during therapy

Frank Neumann, Klaus Mross, Marc Azemar, Vittorio Ziroli, Ulrich Massing, Clemens Unger, Bernd Hildenbrand
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): A50.
Published: 15 August 2014
View article titled, Measuring tumor cell apoptosis and necrosis in blood samples of cancer patients during therapy
Journal Articles

Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.

Boris Kubuschok, Frank Neumann, Rainer Breit, Martina Sester, Claudia Schormann, Claudia Wagner, Urban Sester, Frank Hartmann, Mathias Wagner, Klaus Remberger, Martin Schilling, Michael Pfreundschuh
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (4): 1365–1372.
https://doi.org/10.1158/1078-0432.CCR-05-1672
Published: 17 February 2006
View article titled, Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
Open the PDF for Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer. in another window